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I. Introduction 
The United Kingdom (UK) former Agriculture
Minister Jim Paice declared in January 2012 at the
Oxford Farming Conference that:
‘We can keep the cosy image of Buttercup in the
field producing a few litres a day and the bucolic
farmer leaning on his gate. We can sentimen-
talise farmers as small players in a market domi-
nated by supermarkets at home and multina-
tional conglomerates abroad. Or: we can set this
industry [farming] on fire and take the opportu-
nities, and face the reality that those opportuni-
ties provide; [...] proud to still be producing most
of the food for our people and ready to play our
part in the Foresight challenge to feed the
world’.1
This attitude reflects the new governmental
approach towards new technologies.2 Modern
agricultural biotechnology must play a central
role in sustainable intensification to attain food
security.3
Since the Coalition Government took power in
May 2010, it has been offering its backing and
support to modern agricultural biotechnology and
its industry. The former Secretary of State for
Environment, Food and Rural Affairs, Caroline
Spelman has made repeated calls for a green global
economy where natural resources, science and
technology play central stage.4 More importantly,
within the following days of the establishment
of the Coalition Government, the Department for
Environment, Food and Rural Affairs (DEFRA)
authorised a field trial of a GM potato in Nor-
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1 Former Agriculture Minister Jim Paice, “Jim Paice’s Speech at
the Oxford Farming Conference 2012”, 4 January 2012, available
on the internet at <http://www.defra.gov.uk/news/2012/01/04/
jim-paice-speech-oxford-farming-conference-2012/> (last
accessed on 20 November 2012). In September 2012, the UK
Prime Minister David Cameron, reshuffled his government and
the current Agriculture Minister is David Heath.
2 From the outset, the market prospects that could provide 
modern agricultural biotechnology to the UK economy are
underlined.
3 Genetic modification and animal cloning are part of modern
agricultural biotechnology. The purpose of animal cloning is 
to be used as an assisted reproductive technology for breeding
animals and to use the sexually-reproduced offspring of clones 
for food production.
4 See for instance, former Environment Secretary Caroline 
Spelman, “Caroline Spelman’s Speech at the Oxford Farming
Conference 2012”, 4 January 2012, available on the internet at
<http://www.ofc.org.uk/files/ofc/papers/caroline-spelman.pdf>
(last accessed on 20 November 2012). Also, in May 2010 
Caroline Spelman declared that she favoured GM foods ‘in 
the right circumstances’ as ‘GM can bring benefits in food to 
the marketplace’. See Juliette Jowit and JohnVidal, “Environment
Secretary Caroline Spelman Backs GM Crops”, The Guardian,
4 June 2010. The current Environment Secretary is Owen Paterson.
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A renaissance of modern agricultural biotechnology to achieve food security is occurring
in the UK, where animal cloning is moving centre stage. By establishing limited regula-
tion and labelling and, therefore, limited controls on cloned animals, their progeny, and
their derived foods, the UK favours the development of the technology. However, this
regime reduces information for consumers and their freedom of choice. The new approach
contrasts with a growing tendency to accommodate consumer preferences when
regulating – as demonstrated by the positions endorsed by individual EU institutions –
which weakens the legitimacy and the effectiveness of the UK regulatory intervention.
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folk.5 Also, in September 2011, DEFRA issued its
consent to an application from Rothamsted Re-
search to carry out a trial of a GM wheat resistant to
aphids.6 Indeed, the Government has reinforced
its willingness to commercialise GMOs.
Genetic modification is not the only technology
to be favoured by the new government’s position,
animal cloning for food production also benefits
from it.7 Both animal cloning and GMOs could
potentially in the long-term offer a possible solution
for food crises and shortages and play a determin-
ing role in achieving food security. Nonetheless,
GMOs and animal cloning are contested because of
the scientific uncertainty that surrounds them and
the potential risks they raise. In relation to GMOs
there are mainly two types of concerns: first, there
is the question of the unknown long term effects of
consuming GM crops/foods on humans (allergic
reactions); and second, they can have effects on the
environment per se (superweeds and reduction of
biodiversity).8 Concerning animal cloning, the over-
all success rate of the cloning procedure is still low.
The cloning efficiency of cattle, namely the per-
centage of viable offspring born from transferred
embryo clones, is around 10 %; and that of pigs
around 6 %.9 Animal cloning could lead to a reduc-
tion in the genetic diversity of farmed animals.10 It
can further push the evolution of genes in a single
direction and new traits could be missed. The Euro-
pean Group on Ethics in Science and New Technolo-
gies (EGE) also concluded that ‘considering the level
of suffering and health problems of surrogate dams
and animal clones, it had doubts as to whether
cloning for food was justified’.11 It did not see any
convincing arguments to justify the production
of food from clones and their offspring.12 Despite
such controversy, in 2008, the European Food
Safety Authority (EFSA) concluded that meat and
milk from clones and their progeny were safe even
though ‘the health and welfare of a significant
proportion of clones [...] have been found to be
adversely affected, often severely and with a fatal
outcome’.13
The regulation of new technologies is not un-
problematic for states. Over the past decades, as a
‘scientization of risk’ has occurred, risks are fre-
quently being defined and measured according to
scientific principles – as demonstrated by the EFSA
opinion.14 Scientific principles are widely domi-
nant which can lead to the marginalisation of other
relevant considerations. Risk has multiple dimen-
sions; it has implications and meaning beyond sci-
entifically quantified expressions of magnitude and
effect. Risk is ‘not [only] a matter of simple proba-
bilities to be rationally calculated by experts and
avoided in accordance with the cold arithmetic of
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5 It may be noted that consent had also been granted shortly before
the election for a similar trial of GM blight-resistant potatoes at
the University of Leeds. See DEFRA, “Part B Consents Granted to
Release Genetically Modified Organisms”, 3 February 2012, avail-
able on the internet at <http://archive.defra.gov.uk/environment/
quality/gm/regulation/registers/consents/index.htm> (last accessed
on 20 November 2012). In the UK, DEFRA is the main govern-
ment department on the environmental safety of GMO releases
and also considers wider issues surrounding the use of GM crop
technology, while the Food Standards Agency leads on the safety
of GM food and feed, and responsible for novel foods more
generally. 
6 DEFRA, “Genetic modification (GM)”, 28 September 2012,
available on the internet at <http://www.defra.gov.uk/environment/
quality/gm/> (last accessed on 20 November 2012).
7 When relevant, references will be made to GMOs. Comparisons
between the more established genetic modification and the less
established animal cloning and their derived products create a
good opportunity to look for progression.
8 For more on GMOs and their regulation, see for example, Maria
Lee, EU Regulation of GMOs: Law, Decision-making and New
Technology (Cheltenham: Edward Elgar 2008); Theofanis Christo-
forou, “The Regulation of Genetically Modified Organisms in
the European Union: the Interplay of Science, Law and Politics”,
41 Common Market Law Review (2004), pp. 637 et sqq.; and
Helle Anker and Margareth Grossman, “Authorization of
Genetically Modified Organisms: Precaution in US and EC Law”,
4 European Food and Feed Law Review (2009), pp. 3 et sqq.
9 EFSA, Update on the state of play of Animal Health and Welfare
and Environmental Impact of Animals derived from SCNT
Cloning and their Offspring, and Food Safety of Products
Obtained from those Animals (2012), at p. 18. See also EFSA,
Final Scientific Opinion on the Food Safety, Animal Health and
Welfare and Environmental Impact of Animals derived from
Cloning by Somatic Cell Nucleus Transfer (SCNT) and their
Offspring and Products Obtained from those Animals (2008), 
at p. 18.
10 National Standing Committee on Farm Animal Genetic
Resources, “Statement on Cloning of Farm Animals”, June 2011,
available on the internet at <http://archive.defra.gov.uk/fangr/
documents/100914-cloning-statement.pdf> (last accessed on
20 November 2012). The National Standing Committee on Farm
Animal Genetic Resources was set up in 2008 to advise on
implementation of the UK National Action Plan on Farm Animal
Genetic Resources and to provide technical advice on policy
matters relating to the conservation and sustainable use of farm
animal genetic resources.
11 European Group on Ethics in Science and New Technologies,
Opinion No 23 on the Ethical Aspects of Animal Cloning for
Food Supply (2008), at p. 45.
12 Ibid.
13 EFSA, 2008 Opinion of Animal Cloning, supra note 9, 
at p. 32. 
14 See, e.g., Ulrich Beck, Risk Society: Towards a New Modernity
(M. Ritter tr; London: Sage 1992), at p. 56.
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cost-benefit analysis’.15 Rather, risk is ‘part of the
modern human condition, woven into the very
fabric of progress’.16 There is a close relationship
between science, risk and society. Science is not self-
sufficient and is to be seen in context. Science and
technology both embed and are embedded in social
practices, identities, and institutions.17 Conse-
quently, decision-makers, when regulating new
technologies, have to balance the differing views of
stakeholders (public, politicians and scientists) over
risks and how these should be regulated as well as
which factors should be relevant. Animal cloning
and its derived foods are the prime example of such
disagreement – as will be observed in this article.
Because of the new UK pro-biotech stance,
changes are noticeable in the UK policy on animal
cloning and its resulting foods. As will be seen, the
government prefers relatively light regulation and
few labelling obligations, which impacts on con-
sumer information and their ability to take
informed decisions. Such a policy could create
regulatory issues in relation to the risks created
by cloning as a new technique; its compatibility
with the European Union (EU) policy and law; and,
its impact on consumer choice. As identified by
Brownsword, regulatory interventions should be
legitimate and effective to achieve specific regula-
tory purposes.18 If they fulfil both conditions, regu-
lators are proceeding in ‘the right kind of way’.19
Keeping this in mind and the fact that the new
policy could raise regulatory issues, this article will
try to determinate whether the new regulatory
framework for animal cloning for farming purposes
fulfil such conditions. 
This article will explore the policy of the Coali-
tion Government on modern agricultural biotech-
nology before focussing on the position on animal
cloning including cloned foods and their labelling.
It will further analyse whether such an approach
is in line with the EU institutions by analysing the
collapse of the review of the 1997 Novel Foods
Regulation. Finally, the extent to which consumer
preferences should be taken into account by regula-
tors will be assessed. 
II. The UK Approach: Modern
Agricultural Biotechnology 
is the Way Forward 
The 2011 Foresight Report on The Future of Food
and Farming: Challenges and Choices for Global
Sustainability from the Government Office for Sci-
ence identifies food security as a governmental
priority as well as sustainability.20 Food security
and sustainable agriculture are closely intercon-
nected as a sustainable agricultural production and
a sustainable food chain can help fighting and tack-
ling hunger.21 In order to achieve such priorities,
the Foresight Report calls for the appraisal of mod-
ern biotechnology as it is capable of delivering
resilient high levels of productivity.22
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15 Sheila Jasanoff, “Technologies of Humility: Citizen Participation
in Governing Science”, 41 Minerva (2003), pp. 223 et sqq., at
p. 224.
16 Ibid.
17 Sheila Jasanoff, “The Idiom of Co-production”, in Sheila 
Jasanoff (ed), States of Knowledge: The Co-production of 
Science and the Social Order (London: Routledge 2006), pp. 1
et sqq., at p. 3.
18 Richard Brownsword, Rights, Regulation, and the Technological
Revolution (Oxford: OUP 2008).
19 Ibid 9.
20 The Government Office for Science, Foresight Report on The
Future of Food and Farming: Challenges and Choices for Global
Sustainability (2011), at p. 5. The report defines sustainability as
implying ‘the use of resources at rates that do not exceed the
capacity of the earth to replace them’ that is ‘a system or state
where the needs of the present and local population can be met
without diminishing the ability of future generations or popula-
tions in other locations to meet their needs and without causing
harm to the environment and natural assets’ See respectively
p. 72 and 204. See also, DEFRA, “Caroline Spelman Speech to
Food and Drink Association on ‘Secure and Sustainable Food –
The Rio+20 Challenge”, 24 May 2012, available on the internet
at <http://www.defra.gov.uk/news/2012/05/24/caroline-spelman-
speech-to-food-and-drink-association-on-secure-and-sustainable-
food-the-rio20-challenge/> (last accessed on 20 November
2012).
21 See for instance, European Commission, “Fighting hunger”,
3 October 2012, available on the internet at <http://ec.europa.eu/
europeaid/what/food-security/index_en.htm> (last accessed on
20 November 2012); European Commission, “Food waste”,
<http://ec.europa.eu/food/food/sustainability/index_en.htm> 
(last accessed on 20 November 2012); Michael Cardwell,
“European Union Agricultural Policy and Practice: the New
Challenge of Climate Change” 13 Environmental Law Review
(2011), pp. 271 et sqq., at p. 271. The Foresight report defines
sustainable intensification as ‘the pursuit of the dual goals of
higher yields with fewer negative consequences for the environ-
ment’ for three reasons: (i) that there is relatively little new land
for agriculture; (ii) that more food needs to be produced; and (iii)
that food production must become sustainable. Foresight Report,
supra note 20, at p. 73.
22 Ibid 88 and167. See also, Paice’s Speech at Oxford Farming
Conference, supra note 1, where Jim Paice describes sustainable
intensification as ‘using less and producing more’.
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As GM crops and animal cloning are identified as
having the potential to feed more people than ever
before, partnerships between research, technology
and knowledge transfer should be increased to
favour modern agricultural biotechnology.23 Cur-
rently, the UK government spends £400 million a
year on agricultural science, such as research into
crop and livestock genetics to increase the competi-
tiveness of UK farming and to contribute to ‘tack-
ling global food security’.24 Therefore, favouring the
development of modern agricultural biotechnology
also has economic justifications.
The DEFRA stance is based on and informed
by the report: it identified food sustainability and
security as some of its main aims and modern agri-
cultural biotechnology, with its economic potential,
as a solution to such challenges. For instance, in
his speech as DEFRA chief scientific adviser at the
2012 Oxford Farming Conference, Bob Watson
confirmed that new technologies such as livestock
genomics and GMOs are central to DEFRA policy
on food and farming.25 This is also exemplified
by recent speeches of Caroline Spelman where the
goals are a ‘green and growing economy’ where the
biotech industry plays a determining role.26
The governmental priority to use GMOs and
animal cloning for farming purposes seems, non-
etheless, to be underpinned by scientific uncer-
tainty and concerns. It appears, however, that the
government is aware of the potential risks and
concerns created by modern agricultural biotech-
nology but has made a policy decision to trade an
element of biodiversity for increased production
and economic growth to achieve food security and
more importantly a ‘green and growing economy’. 
Because technological innovations command
enormous rewards in the marketplace, economic
considerations are often considered enough to
‘drive science through the pipeline of research
and development into commercialization’.27 This
is confirmed in the words of Beck who states that
‘the first priority of techno-scientific curiosity is
utility for productivity’.28 Economic growth is a
legitimation of the policy on modern agricultural
biotechnology.
This pro-biotech stance recalls the 2002 Euro-
pean Communication on ‘Life Sciences and Biotech-
nology – A Strategy for Europe’ where even though
the Commission states that there is a choice to be
made for the EU between being proactive or pas-
sive, it is pretty clear that, for the Commission, there
is only one policy choice: the EU must play an
active role in the development of modern agri-
cultural biotechnology.29 The strategy remains a
‘necessary policy objective’ reinforcing competitive-
ness.30 It seems contrary to the concept of co-pro-
duction, which attaches science, facts and policy
together with culture, values and other social
dimensions,31 as it fails to take into account con-
sumer views. Similar aspirations permeate the UK
position. It appears to follow the impetus of the
Strategy for Europe, where fostering technological
innovation and re-building a strong economy are
the priorities rather than considering the public
perspective. 
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23 Foresight Report, supra note 20, at p. 88.
24 Spelman’s Speech at Oxford Farming Conference, supra note 4.
See also Foresight Report, supra note 20, at p. 34.
25 Bob Watson, “Bob Watson’s Speech at the Oxford Farming
Conference 2012”, 4 January 2012, available on the internet at
<http://www.ofc.org.uk/files/ofc/papers/bob-watson.pdf>
(last accessed on 20 November 2012).
26 See, DEFRA, “Caroline Spelman Speech at Planet Under Pressure
Conference”, 26 March 2012, available on the internet at
<http://www.defra.gov.uk/news/2012/03/26/caroline-spelman-
speech-planet-under-pressure-conference/> (last accessed on
20 November 2012); Andrew Sparrow, “Caroline Spelman
Interview: ‘It’s in Our Interests to be Green and Growing’”,
The Guardian, 15 June 2012; and Fiona Harvey, “Drought May
Be New Norm for UK, Says Environment Secretary”, The
Guardian, 21 February 2012.
27 Michael Aaron Dennis, “Reconstructing Sociotechnical Order:
Vannevar Bush and US Science Policy” in Sheila Jasanoff (ed),
States of Knowledge: The Co-production of Science and the
Social Order (London: Routledge 2006), pp. 225 et sqq., at
p. 228.
28 Beck, Risk Society, supra note 14, at p. 60.
29 Commission Communication on ‘Life Sciences and Biotech-
nology – A Strategy for Europe’ (Strategy for Europe) COM(2002)
27, at p. 3: ‘Europe is faced with a major policy choice: either
accept a passive and reactive role, and bear the implications
of the development of these technologies elsewhere, or 
develop proactive policies to exploit them in a responsible
manner, consistent with European values and standards. The
longer Europe hesitates, the less realistic this second option 
will be’.
30 Marine Friant-Perrot, “The European Union Regulatory Regime
for Genetically Modified Organisms and its Integration into
Community Food Law and Policy” in Luc Bodiguel and Michael
Cardwell (ed), The Regulation of Genetically Modified Organ-
isms: Comparative Approaches (Oxford: OUP 2010), pp. 79
et sqq., at p. 79.
31 Jasanoff, “Co-production”, supra note 17, at p. 3.
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III. The UK Policy on Animal Cloning
and its Derived Foods
DEFRA and the Food Standards Agency (FSA) have
given a green light for the use of animal cloning in
farming. The current policy is based on a narrow
definition of a ‘cloned food’ which, as a conse-
quence, excludes products from the offspring of
clones from such a definition. This leads to the lim-
ited labelling of cloned foods as only the products
from clones themselves could be labelled – and not
the foods from the offspring. As will be shown,
these three policy components again demonstrate
the economic motivation behind the policy. 
1. No Ban on Animal Cloning
For the UK government a ban on animal cloning,
use of clones and food from clones would be dis-
proportionate in terms of food safety and animal
welfare.32 DEFRA reached such a conclusion after
reviewing the latest advice from the EFSA and from
the national Advisory Committee on Novel Foods
and Processes (ACNFP).33 Another UK advisory
body, the National Standing Committee on Farm
Animal Genetic Resources, found similar conclu-
sions.34 In its statement, the National Standing
Committee, nonetheless, alerts breed societies and
breeders to take steps to ‘minimise inbreeding and
to ensure sufficient diversity within breeds to
ensure their future “genetic health”’ as diversity is
the basis of breed improvement.35 Therefore, the
committee warns against a major drawback of
using animal cloning as it could lead to a reduction
of the gene pool. Such a danger, however, is not
expressly mentioned in any FSA or DEFRA docu-
ment. The Foresight report is, however, more
nuanced, as it warns against the human and
environmental safety of any new technology to be
rigorously established before its use.36
Yet again, the government focuses on economic
considerations. It also shows that a precautionary
approach has not been adopted by the government.
The precautionary principle modifies the role of
scientific data in cases of scientific uncertainty. It
directs to a decision to act or not to act and helps
determine which measures should be adopted. It
also looks at non-scientific conceptions of risk.37
The precautionary principle has become a tenet of
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32 DEFRA, “Cloning of Farmed Animals”, 30 August 2011, 
available on the internet at <http://www.defra.gov.uk/
food-farm/animals/cloning/> (last accessed on 20 November
2012) and Hansard (House of Commons) Vol.527, Part 147,
Col.2W. 
33 See EFSA, “Update on the State of Play of Animal Cloning”,
17September 2010, available on the internet at <http://www.efsa.
europa.eu/en/efsajournal/pub/1784.htm> (last accessed on 20
November 2012) and FSA, “Cloned Meat is Safe – Hypothetical-
ly Speaking”, 25 November 2010, available on the internet at
<http://www.food.gov.uk/news/newsarchive/2010/nov/acnfcloned>
(last accessed on 20 November 2012). The ACNFP is an inde-
pendent body of scientific experts that advises the FSA on any
matters relating to novel foods and carries out safety assessments
of any novel food submitted for approval under the Novel Foods
Regulation. 
34 National Standing Committee, “Statement on Cloning of Farm
Animals”, supra note 10. 
35 Ibid.
36 Foresight Report, supra note 20, at p. 167. In the conclusions 
of the report, a more cautious approach seems to be given 
to new technologies, such as GMOs and animal cloning, 
to think very carefully about the impact of such technologies 
on the public, farmers and other stakeholders along the food
chain.
37 See Directive 2001/18/EC of the European Parliament and of the
Council of 12 March 2001 on the Deliberate Release into the
Environment of Genetically Modified Organisms and repealing
Council Directive 90/220/EEC OJ 2001 L 106/1; Regulation (EC)
No 1829/2003 of the European Parliament and of the Council of
22 September 2003 on Genetically Modified Food and Feed
OJ 2003 L 268/1; Regulation (EC) 1830/2003 of the European
Parliament and of the Council of 22 September 2003 concerning
the Traceability and Labelling of Genetically Modified Organisms
and the Traceability of Food and Feed Products produced from
Genetically Modified Organisms and amending Directive
2001/18/EC OJ 2003 L 268/24. At the European level, the pre-
cautionary principle is a cornerstone of EU environmental law
and policymaking: Article 191(2) Consolidated Version of the
Treaty on the Functioning of the European Union (TFEU)
OJ 2008 C 115/47. A full analysis of the role of precautionary
principle is outside the scope of this article. For a detailed
examination of the role of the precautionary principle, see, e.g.,
Nicolas De Sadeleer, Environmental Principles: From Political
Slogans to Legal Rules (Oxford: OUP 2007); Timothy O’Riordan,
James Cameron and Andrew Jordan, Re-interpreting the Precau-
tionary Principle (London: Cameron and May 2001); Elizabeth
Fisher, Judith Jones and René von Schomberg, Implementing the
Precautionary Principle: Perspectives and Prospects (Cheltenham:
Edward Elgar 2006); David Freestone and Ellen Hey, The Precau-
tionary Principle and International Law: The Challenge of Imple-
mentation (The Hague: Kluwer Law International 1996); Elen
Stokes, “The Role of Risk Assessment in Precautionary Interven-
tion: A Comparison of Judicial Trends in the EC and WTO”
4 Journal for European Environmental Planning Law (2007),
pp. 455 et sqq.; Naomi Salmon, “A European Perspective on
the Precautionary Principle, Food Safety and the Free Trade
Imperative of the WTO” 27 European Law Review (2002), pp.
138 et sqq.; Nicolas de Sadeleer, “The Precautionary Principle
in EC Health and Environmental Law” 12 European Law Journal
(2006), pp. 139 et sqq.
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the regulation of modern agricultural biotechnol-
ogy.38 This is demonstrated by the regime existing
for GMOs and their derived foods, which put in
place pre-market authorisation, mandatory labelling
and traceability. The European Court of Justice
has defined the precautionary principle in the Arte-
godan case ‘as a general principle of Community
law requiring the competent authorities to take
appropriate measures to prevent specific potential
risks to public health, safety and the environment,
by giving precedence to the requirements related to
the protection of those interests over economic
interests’.39 Non-economic considerations can be
the basis of regulation. Therefore, the food safety
issues, long-term concerns, consumer worries and
animal health and welfare issues raised by animal
cloning seem to call for the application of the pre-
cautionary principle. The principle is, nevertheless,
playing a marginal role in the regulation of animal
cloning in the UK. The UK assumes the safety of
cloned foods as demonstrated by the ACNFP and
the EFSA opinion and therefore chose to give pref-
erence to economic considerations rather than con-
sumer concerns.
In relation to animal welfare, the government
declared that ‘the welfare of all farmed animals,
including clones and their descendants, is already
protected by current welfare legislation’.40 Animal
cloning for farming purposes appears, however, to
be contrary, for example, to paragraphs 28 and 29
of Schedule I to the Welfare of Farmed Animals
(England) Regulations 2007 which provides that:
‘[n]atural or artificial breeding or breeding proce-
dures which cause, or are likely to cause, suffering
or injury to any of the animals concerned, must not
be practised’41 because of the issues of animal
welfare and suffering that it raises. Therefore, based
on those regulations the UK government could have
banned animal cloning.42
Embracing modern agricultural biotechnology, as
it favours the development of new industry and
reinforces scientific innovation in the UK economy,
emerges as a commercial imperative. There appears
to be only one policy option: taking a leading role in
modern biotechnology. 
2. A Narrow Definition of Cloned Foods 
The regulation of cloned foods falls under Regula-
tion (EC) No 258/97 concerning Novel Foods and
Novel Food Ingredients (Novel Foods Regulation) –
as there is no national law specifically dealing with
novel foods.43 Cloned food would fall most natu-
rally under category (e) of Article 1 (2) of the Novel
Foods Regulation.44 Under this regulation, meat
and milk derived from cloned animals and their
progeny could potentially require pre-market autho-
risation and labelling.45
Since the emergence of cloned foods, and until
May 2011, the FSA position in relation to cloned
foods was that ‘products from the offspring of
cloned animals, like those from cloned animals
themselves, should be considered as novel foods’.46
They would therefore have to undergo the proce-
dure exiting under the Novel Foods Regulation. In
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38 See for instance, Zeynep Kivilcim Forsman, “Community Regula-
tion of Genetically Modified Organisms: a Difficult Relationship
Between Law and Science” 10 European Law Journal (2004),
pp. 580 et sqq., at p. 583. The key case on the precautionary
principle and modern agricultural biotechnology is the Green-
peace v. France case. See Case C-6/99, Association Greenpeace
France and Others v. Ministère de l’Agriculture et de la Pêche
and Others [2000] ECR I-1676. For, De Sadeleer, the Greenpeace
v. France case ‘implicitly confirmed that recourse to the precau-
tionary principle could put a stop to the free circulation of
GMOs’. See, De Sadeleer, “The Precautionary Principle in EC”,
supra note 37, at p. 144.
39 Joined cases T-74/00, T-76/00, T-83/00, T-84/00, T-85/00, T-132/00,
T-137/00 and T-141/00 Artegodan GmbH and Others v. Com-
mission of the European Communities [2002] ECR II-4945, at
para. 184. See also Communication from the Commission on
the Precautionary Principle COM(2000) 1.
40 DEFRA, “Cloning of Farmed Animals”, supra note 32 and
Hansard (House of Commons) Vol.527, Part 147, Col.2W.
41 Schedule I to the Welfare of Farmed Animals (England) Regula-
tions 2007, SI 2007/2078, at para. 28. Paragraph 29: ‘Animals
may only be kept for farming purposes if it can reasonably be
expected, on the basis of their genotype or phenotype, that they
can be kept without any detrimental effect on their health or
welfare’. Those regulations implement Council Directive
98/58/EC of 20 July 1998 concerning The Protection of Animals
Kept for Farming Purposes, OJ 1998 L 221/23.
42 As will be analysed in the next section, the EU institutions had
‘agreed’ on a ban on animal cloning.
43 Regulation (EC) No 258/97 of the European Parliament and of
the Council of 27 January 1997 concerning Novel Foods and
Novel Food Ingredients OJ 1997 L 43/1.
44 Novel Foods Regulation, supra note 43, Article 1 (2)(e): ‘foods
and food ingredients consisting of or isolated from plants and
food ingredients isolated from animals, except for foods and
food ingredients obtained by traditional propagating or breeding
practices and having a history of safe food use’. The Novel Foods
Regulation will be analysed further in section IV.1.
45 Ibid Articles 5 and 8.
46 FSA, “Cloned offspring novel food, says Agency”, 18 January
2007, available on the internet at <http://www.food.gov.uk/
news/newsarchive/2007/jan/clonedoffspring> (last accessed
on 20 November 2012).
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May 2011, the FSA changed its position in relation
to the offspring of clones. It declared that it was
adopting a similar position to the position taken by
the European Commission that ‘there are no food
safety grounds for regulating foods from the
descendants of cloned cattle and pigs, food obtained
from the descendants of clones of cattle and pigs
does not require authorisation [or mandatory
labelling] under the novel foods regulation’.47 This
is in line with DEFRA and Jim Paice’s positions and
is now government policy.48
The existing policy does not subject the product
of the descendants of cloned animals to any specific
pre-market authorisation, labelling or traceability –
contrary to the regime that exists for GMOs and
their resulting foods. Therefore, fewer requirements
will be imposed on farmers and other food pro-
cessors, which could increase potential trade and
competitiveness. The FSA also specified that this
policy modification would appear to accommodate
businesses willing to market such foods, even
though the FSA was not in a position to assess the
scale of this possible impact.49 Economic reasons
are, yet again, used to justify this liberal approach.
Therefore, increased growth and competitiveness
are the regulatory purposes of this new policy on
animal cloning and are used as a legitimation for
this relaxed position.
This change in policy would seem possible as the
terms ‘[novel foods] obtained by traditional breed-
ing practices’ under Article 1(2)(e) of the Novel
Foods Regulation can be interpreted in two ways
according to the FSA.50 On the one hand, it can
mean that the regulation applies to the progeny of a
cloned animal as the offspring would not exist with-
out the original non-traditional breeding practice,
that is cloning. Descendants should thus not be
regarded as ‘obtained by traditional breeding prac-
tices’ and should therefore go through an authorisa-
tion process and be labelled. On the other hand, the
legislation can also be interpreted to apply only to
food from cloned animals themselves and not to the
progeny as the latter is ‘obtained by traditional
breeding’. Therefore, foods from the offspring of
clones would not have to be authorised or labelled
as they would fall outside the scope of the Novel
Foods Regulation.51 This second interpretation is
the one now adopted by the government which
means that currently meat and milk from the off-
spring of clones could end up on the food shelves
without being pre-authorised or require any specific
labelling as they would be considered as similar to
any other conventional food. This limits to a huge
extent the capacity of consumers to take informed
decisions.
3. The Limited Labelling of Cloned
Foods
Under the general labelling requirements of the
1996 Food Labelling Regulations, all foods must be
marked or labelled with ‘particulars of the place
of origin or provenance of the food if failure to give
such particulars might mislead a purchaser to a
material degree as to the true origin or provenance
of the food’.52 Therefore, not labelling the correct
provenance of the food – that is where the food
originates i.e. its cloned animal origin – could be a
misdescription of the food, which would lead to
mislabelling and deceiving consumers. Moreover,
under the regulation consumers are misled if there
is the omission of an indication of physical condi-
tions or treatment.53 This specifically refers to the
nature of the food, its method of manufacture or
production and cloning constitutes such a process.
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47 FSA, “Meat and milk from cloned animals”, 7 December 2010,
available on the internet at <http://www.food.gov.uk/news/
newsarchive/2010/dec/boardcloning> (last accessed on 20
November 2012). See also, FSA, “‘Novel’ Status of Food from
Descendants of Cloned Cattle and Pigs”, available on the internet
at <http://www.food.gov.uk/policy-advice/novel/cloned/> (last
accessed on 20 November 2012). Such a position was adopted
after the views of interested parties was received, even though
many responses dealt with the concerns over food safety, animal
welfare and consumers’ values.
48 DEFRA, “Cloning of Farmed Animals”, supra note 32 and
Hansard (House of Commons) Vol. 527, Part 147, Col. 2W.
49 FSA, “Meat and milk from cloned animals”, supra note 47.
50 The two interpretations were put forward by the FSA in its letter
to stakeholders to seek their views on a potential change in its
interpretation of the Novel Foods Regulation in respect of food
from the descendants of cloned cattle and pigs. FSA, “Letter
to Interested Parties on the Food from the Descendants of 
Cloned Animals”, 13 January 2011, available on the internet at
<http://www.food.gov.uk/multimedia/pdfs/cloningletterjan11.pdf>
(last accessed on 20 November 2012). See also, DEFRA,
“Cloning of Farmed Animals”, supra note 32. For more on the
regulation of cloned foods at EU level, see, e.g., Ludivine Petetin,
“Clone Wars? The Challenges of Cloned Food in EU, US and
WTO Law” 11 Environmental Law Review (2009), pp. 246 et sqq.
51 The Novel Foods Regulation will be further developed in section
IV.
52 The Food Labelling Regulations 1996, SI 1996/1499, regulation
5(f).
53 Ibid regulation 11 and schedule 2.
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Therefore, not describing that a food comes from a
cloned animal or its progeny could arguably create
a mislabelling of the food because of its misdescrip-
tion.
DEFRA and the FSA are satisfied with the poten-
tial pre-market authorisation for cloned foods and
their labelling under the Novel Foods Regulation
but not for the food deriving from the offspring of
clones.54 For the FSA the mandatory labelling of
meat and milk obtained from the descendants of
cloned cattle and pigs is unnecessary and dispropor-
tionate.55 DEFRA added that ‘mandatory labelling
of meat or milk products derived from animals with
a clone in their ancestry would be unenforceable
and impractical’ as there is ‘no traceability system
that can be applied to either imported or home pro-
duced products from descendants of clones’ and
that ‘the cost of introducing such a system [...] can-
not be justified’.56
The argument that there is no method for the
identification and traceability of farm animals pro-
duced by different breeding practices may be ques-
tioned. First, the fact that it might be currently
impossible to determine by examination or testing
which breeding practices were used to obtain a spe-
cific animal could change in the future as scientific
innovations become more robust. Second, a system
of identity preservation, traceability and labelling
could be established. For example, as a consequence
of the BSE crisis, Council Regulation (EC) No 820/97
and Regulation (EC) No 1760/2000 established a
regime of individual traceability of cattle by means
of individual identification of animals with ‘double
ear tag’, ‘holding register’, ‘cattle passport’ and ‘com-
puterised database’.57 Third, a recent Commission
proposal amending Regulation (EC) No 1760/2000
recommends the simplification of information obli-
gations by introducing bovine electronic identifica-
tion to improve the existing systems of cattle identi-
fication.58 This new system which allows the track-
ing of individual animals and their ancestors could
be used and adapted in husbandry to limit the
issues of the current non-traceability of cloned ani-
mals and their progeny. Fourth, fully traceable
systems have been put in place for voluntary
labelling schemes in supermarkets. For instance,
organic and fair-trade products rely on recordkeep-
ing to document the origin of animals and foods as
well as controls and inspections. Thus, it seems that
the tracing and labelling of cloned animals, their
progeny and their derived products could be
achieved if there was sufficient effort and willing-
ness to do so.
The reasons above given by the FSA and DEFRA
demonstrate that not labelling the products from
the offspring of clones is based purely on economic
considerations, including promoting the competi-
tiveness of the UK biotechnology industry and
promoting economic growth, rather than consumer
choice. In contrast, DEFRA generally acknowledges
that food labelling allows consumers to receive
accurate information and to make informed
choices.59 However, not labelling cloned foods
reduces consumer information and choice. More-
over, the lack of mandatory labelling and traceabil-
ity, and therefore of monitoring could have a nega-
tive impact on consumer confidence in the food
supply – as it did, for example, in the United States
of America after the StarLink™ incident.60
The government overlooks the fact that con-
sumers may want to see effective labelling of prod-
ucts from clones and their offspring. Other rep-
utable bodies, such as the Government Office for
Science and the Royal Society, focus more on taking
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54 Hansard (House of Commons) Vol.527, Part 147, Col.2W.
55 DEFRA, “Cloning of Farmed Animals”, supra note 32.
56 Ibid and Hansard (House of Commons) Vol.527, Part 147, 
Col. 2W.
57 Council Regulation (EC) No. 820/97 establishing a System for the
Identification and Registration of Bovine Animals and regarding
the Labelling of Beef and Beef Products OJ 1997 L 117/1and
Regulation (EC) number 1760/2000 of the European Parliament
and of the Council of 17 July 2000 establishing a System for the
Identification and Registration of Bovine Animals and regarding
the Labelling of Beef and Beef Products and repealing Council
Regulation (EC) number 820/97 OJ 2000 L 204/1.
58 Proposal for a Regulation of the European Parliament and of the
Council amending Regulation (EC) No 1760/2000 as regards
Electronic Identification of Bovine Animals and Deleting the
Provisions on Voluntary Beef Labelling COM(2011) 525 final,
at p. 1.
59 DEFRA, “Food labelling”, September 2011, available on the
internet at <http://www.defra.gov.uk/food-farm/food/labelling/>
(last accessed on 20 November 2012). See more generally: Euro-
pean Commission, White Paper on Food Safety COM(1999) 719
final at p. 32; Caoimhin Macmaolain, EU Food Law: Protecting
Consumers and Health (Oxford: Hart 2007); Paul Weirich (ed),
Labeling Genetically Modified Food: the Philosophical and Legal
Debate (Oxford: OUP 2007).
60 StarLink™ is a variety of Bt corn. It was only allowed for com-
mercialisation as animal feed because a small number of people
might develop an allergic reaction to the Bt protein used in
StarLink™. However, it was subsequently found in food destined
for consumption by humans. See In re StarLink Corn Products
Liability Litigation 212 F Supp 2d 828 (ND Ill 2002).
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into account the views of the public.61 They adopt a
more nuanced view: pro-science but with a much
greater emphasis on consumer stance. Also, it might
appear that the government is now in danger of
repeating the experience with GMOs. Similar exam-
ples could be found at EU level in relation to the
regime for GMOs and their resulting foods as well
as the ban on recombinant bovine somatotropin
(rBST).62
The governmental approach towards the regula-
tion of animal cloning and cloned foods is in oppo-
sition with the political momentum existing in
the EU institutions, momentum which is, at least in
principle, more respectful of consumer preferences
and concerns as well as animal welfare – as will be
now seen.
IV. The Failure of the Novel Foods
Proposal
Although at present no specific authorisation proce-
dure exists for regulating food from cloned animals,
cloned foods fall under category (e) of Article 1 (2)
of the Novel Foods Regulation, as mentioned ear-
lier.63 The Novel Foods Regulation creates a har-
monised procedure for the placing on the market
within the EU of novel foods. Nonetheless, by 2006,
an explanatory document had described why the
Novel Foods Regulation had to be modified:64 first,
to clarify the legislation after the removal of GM
food from the scope of the regulation (as Regulation
(EC) No 1829/2003 on Genetically Modified Food
and Regulation (EC) 1830/2003 concerning the
Traceability and Labelling of Genetically Modified
Organisms and the Traceability of Food and Feed
Products produced from Genetically Modified
Organisms regulate GM food and feed and their
labelling65 now regulate GM foods); second, to cre-
ate a more favourable environment for innovation
for the food industry; third, to facilitate internal and
external trade; and, fourth, to allow consumers
to benefit from a wider choice of safe novel foods.
The second and third reasons clearly show, once
again, the economic and commercial considerations
behind such a desired change in the law. These
considerations are, nevertheless, put into a social
context where consumers are considered. However,
the document fails to mention that the concept of
substantial equivalence, on which the Novel Foods
Regulation is based, created huge controversy, con-
troversy which also needed to be remedied.
During the review of the Novel Foods Regulation,
the position of the EU political institutions shifted.
Two main elements emerged as central to the
negotiations of the Novel Foods Proposal: a ban on
animal cloning for food consumption and the
labelling of cloned foods. Nonetheless, cloned foods
currently fall under the scope of the Novel Foods
Regulation, as its review failed in March 2011.
1. The Novel Foods Regulation and the
Concept of Substantial Equivalence 
The Novel Foods Regulation defines novel foods, as
foods that ‘have not hitherto been used for human
consumption to a significant degree within the
Community’.66 When this regulation was enacted,
both GM and cloned foods fell under its scope. 
Substantial equivalence is the criterion by which
the evaluation of novel foods will be weighed when
an applicant notifies the placing on the market
to the national competent authority.67 Substantial
equivalence relies on the comparative analysis of
conventional and biotech foods. It is a procedure
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61 See for example, Foresight Report, supra note 20, at p. 167 and
p. 172; The Royal Society, “Report on Reaping the Benefits:
Science and the Sustainable Intensification of Global Agricul-
ture” (2009), at p. 51.
62 See the European Communities – Measures Concerning Meat
and Meat Products WT/DS26/AB/R, WT/DS48/AB/R, 16 January
1998 (panel), at para. 10, where the European institutions relied
on EU consumer anxieties to ban the use of rBST.
63 Novel Foods Regulation, supra note 43, Article 1 (2)(e). 
64 Explanatory document: Revision of Regulation (EC) No 258/97
of the European Parliament and of the Council of 27 January
1997 concerning Novel Foods and Novel Food Ingredients 
(31 May 2006) 2.
65 Regulation (EC) No 1829/2003 of the European Parliament and
of the Council of 22 September 2003 on Genetically Modified
Food and Feed OJ 2003 L 268/1 and Regulation (EC) 1830/2003
of the European Parliament and of the Council of 22 September
2003 concerning the Traceability and Labelling of Genetically
Modified Organisms and the Traceability of Food and Feed
Products produced from Genetically Modified Organisms and
amending Directive 2001/18/EC OJ 2003 L 268/24.
66 Novel Foods Regulation, supra note 43, Article 1(2).
67 Ibid Article 5. The OECD developed the concept of substantial
equivalence. See OECD, Safety Evaluation of Foods Derived by
Modern Biotechnology: Concepts and Principles (OECD 1993);
FAO/WHO, Expert Consultation on Biotechnology and Food
Safety (FAO/WHO 1996).
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which has two implications: first, it assesses the
safety of biotech foods; and, second, if substantial
equivalence is established, biotech foods are regu-
lated in the same manner as conventional foods. 
Article 3(1) deals with the scope of the regula-
tion: on the one hand, if a novel food is ‘substan-
tially equivalent’ to an existing food, it falls under
the scope of the ‘simplified procedure’ existing
under Article 3(4). Under the regulation, substantial
equivalence can be established by two means:
either a food is considered to be substantially equiv-
alent to an existing food on the basis of available
and generally recognised scientific evidence; or
substantial equivalence is based on the opinion of a
competent food assessment.68 On the other hand, if
a novel food is not substantially equivalent to an
existing food, pre-authorisation is required and the
food must undergo an ‘initial’ safety assessment
and may then proceed to an EU decision in certain
circumstances.69
Under the Novel Foods Regulation, if novel
foods, such as cloned foods, are substantially equiv-
alent to conventional foods, they would reach the
market without any specific requirements.70 Cur-
rently, following the EFSA risk assessment, cloned
food could then benefit from the ‘simplified proce-
dure’ under Article 3(4) as the EFSA declared that
there was ‘no indication that differences exist in
terms of food safety between food products from
healthy cattle and pig clones and their progeny,
compared with those from healthy conventionally-
bred animals’.71 Thus, no case-by-case risk assess-
ment would be needed for cloned food to enter the
EU market and no specific labelling would be
required under this regulation – contrary to the
authorisation of GM foods. However, because of its
vagueness and its regulatory consequences, the con-
cept attracted criticism. 
Substantial equivalence suffers from the important
failing that the concept has never been properly
defined – as can be observed in the Novel Foods
Regulation. In particular, there is no definition of
‘substantial’ and, consequently, no certainty about
when two foods cease to be substantially equiva-
lent. It is very subjective: ‘no standardized objective
tests for determining equivalence and measuring
substantiality exist’.72 This results in a decision not
to require labelling, facilitating trade but limiting
consumers’ freedom of choice considerably. Yet, for
many consumers, any products derived from mod-
ern agricultural biotechnology are perceived to be
‘fundamentally different from their conventionally
produced counterparts’, regardless of their substan-
tial equivalence.73 Following these concerns and
the Monsanto case, substantial equivalence was
removed from the regulation of GM foods by the
establishment of the Food and Feed Regulation and
Regulation 1830/2003.74 Pre-market authorisation
and mandatory labelling of GM foods as well as
their traceability are now required. Such obligations
constitute big differences between the systems now
in place for cloned and GM foods.
2. A Ban on Animal Cloning
In January 2008, the European Commission
adopted a proposal to revise the Novel Foods Regu-
lation. Cloned food would likely have fallen under
the definition of novel food in Article 3(2)(a)(ii)
which stipulated that ‘novel food means food of
plant or animal origin when to the plant and animal
is applied a non-traditional breeding technique not
used before 15 May 1997’. The proposal aimed to
simplify the existing framework by creating a cen-
tralised EU-level procedure for the assessment and
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68 Novel Foods Regulation, supra note 43, Article 3(4): ‘By way of
derogation from paragraph 2, the procedure laid down in Article
5 shall apply to foods or food ingredients referred to in Article 1
(2) (b), (d) and (e) which, on the basis of the scientific evidence
available and generally recognized or on the basis of an opinion
delivered by one of the competent bodies referred to in Article 4
(3), are substantially equivalent to existing foods or food ingredi-
ents as regards their composition, nutritional value, metabolism,
intended use and the level of undesirable substances contained
therein’.
69 Ibid Article 4.
70 Ibid Article 8.
71 EFSA, Opinion on Animal Cloning 2008, supra note 9, at p. 31.
72 Thomas O. McGarity, “Seeds of Distrust: Federal Regulation of
Genetically Modified Plants” 35 University of Michigan Journal
of Law Reform (2002), pp. 403 et sqq., at p. 429. See also,
Erik Millstone, Eric Brunner and Sue Mayer, ‘Beyond Substan-
tial Equivalence’ 401 Nature (1999), pp. 525 et sqq., at 
p. 526.
73 Naomi Salmon, “What’s ‘Novel’ About It? Substantial
Equivalence, Precaution and Consumer Protection 1997–2004”
7 Environmental Law Review (2005), pp. 138 et sqq., at 
p. 142. 
74 The concept of substantial equivalence and its deficiencies were
at the heart of the 2003 Monsanto case which deals with GM
foods. Case C-236/01, Monsanto Agricoltura Italia SpA and
Others v. Presidenza del Consiglio dei Ministri and Others
[2003] ECR I-8105. For a comment of the case, see Ruby 
R. Fernandez, “Monsanto and the Requirement for Real Risks
in GM Food Regulation” 28 International & Comparative Law
Review (2006), pp. 335 et sqq.
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pre-market authorisation of novel foods and there-
fore established a ‘one door-one key’ procedure
potentially facilitating the sale of cloned foods in
the European market – as it exists for GM foods.75
More importantly, substantial equivalence would
have been removed from the regulation.
During the first reading of the initial proposal
before the European Parliament in 2009, the Mem-
bers of the European Parliament declared their posi-
tion in favour of the removal of cloned foods and
their offspring from the scope of the proposal and
the banning of cloning for farming purposes.76 For
the European Parliament, cloned foods should be
dealt with in a specific regulation.77 It reinforced its
position by referring, first, to the incompatibility of
animal cloning for farming purposes with Council
Directive 98/58/EC of 20 July 1998 concerning the
protection of animals kept for farming purposes, in
particular Articles 20 and 21, and second to the EGE
opinion on animal cloning.78 During the second
reading of the proposal before the European Parlia-
ment in July 2010, MEPs reiterated their objec-
tion.79
The European Parliament seems alert to popular
influence and to consider what the European public
wants.80 Such a result could be attributed to the role
of the Parliament’s Committee on the Environment,
Public Health and Food Safety (ENVI Committee).
The ENVI Committee is one of the most influential
committees in EU policy decisions.81 One of its
main priorities, with environmental and public
health policy, is to look at EU citizens’ concerns in
food safety legislation and policy, and in particular
provide ‘better information for consumers, e.g.
through clearer and unambiguous labelling of
products.’82 Through its activism, the committee
promotes key public concerns and shapes the pub-
lic agenda, which subsequently impact on the Euro-
pean Parliament’s policymaking.83 In the case of
animal cloning and its derived products, it is clearly
obvious that the committee has taken on board con-
sumer concerns.84 It constitutes, therefore, one of
the means to channel consumer preferences and for
them to be expressed. 
In 2009, the Council also declared that animal
cloning for farming purposes and its derived prod-
ucts should be banned and that a specific legislation
on cloning would be desirable to address the vari-
ous aspects of the cloning issue.85 In October 2010,
the Commission aligned itself with the other two
European institutions and changed its earlier
position. It proposed to suspend temporarily the
use of animal cloning for food consumption and
their derived foods, with a review clause after five
years.86 It could be argued that banning cloned
foods undermines consumer choice. However,
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75 Proposal for a Regulation of the European Parliament and of the
Council on Novel Foods, COM(2007) 872 – 2008/0002 (COD)
(2008), at p. 7 and Articles 1 and 19.
76 European Parliament Legislative Report adopted on 25 March
2009, P6_TA-PROV(2009)03-25, Provisional Edition PE 422.707:
European Parliament legislative resolution of 25 March 2009 on
Proposal for a Regulation of the European Parliament and of the
Council on Novel Foods, COM(2007) 872 – 2008/0002 (COD)
(2008), P6_TA-PROV(2009)0171. 
77 Ibid Preamble (16). 
78 Council Directive 98/58/EC of 20 July 1998 concerning The Pro-
tection of Animals Kept for Farming Purposes, OJ 1998 L 221/23.
Article 20: ‘Natural or artificial breeding or breeding procedures
which case or are likely to cause suffering or injury to any of the
animals concerned must not be practised. This provision shall
not preclude the use of certain procedures likely to cause mini-
mal or momentary suffering or injury, or which might necessitate
interventions which would not cause lasting injury, where these
are allowed by national provisions’. Article 21 ‘No animal
shall be kept for farming purposes unless it can reasonably be
expected, on the basis of its genotype or phenotype, that it can
be kept without detrimental effect on its health or welfare’. See
also, EGE, Opinion on the Ethical Aspects of Animal Cloning,
supra note 11.
79 European Parliament Legislative Resolution of 7 July 2010 on
the Council Position at first Reading for adopting a Regulation
of the European Parliament and of the Council on Novel Foods,
amending Regulation (EC) No 1331/2008 and repealing
Regulation (EC) No 258/97 and Commission Regulation (EC) No
1852/2001 (11261/3/2009 – C7-0078/2010 – 2008/0002(COD)).
80 See consumer surveys in section V.1.
81 Most of the European Parliament’s work is undertaken by the
committees, which means that they have a tremendous input
into the policymaking process. See Ken Collins and Charlotte
Burns and Alex Warleigh, “Policy Entrepreneurs: The Role of
European Parliament Committees in the Making of EU Policy”
19 Statute Law Review (1998), pp. 1 et sqq., at p. 6.
82 Europa, “Environment, Public Health and Food Safety”,
<http://www.europarl.europa.eu/committees/en/envi/
members.html#menuzone> (last accessed on 20 November
2012).
83 Christilla Roederer-Rynning, “From ‘Talking Shop’ to ‘Working
Parliament’? The European Parliament and Agricultural Change”
41 JCMS (2003), pp. 113 et sqq., at p. 113.
84 Opinion of the Committee on the Environment, Public Health
and Food Safety on the European Union Strategy for the Protec-
tion and Welfare of Animals 2012–2015 (June 2012), suggestion
9.
85 Preamble (6a) Council Political Agreement on the first reading
of the Proposal for a Regulation of the European Parliament and
of the Council on Novel Foods, COM(2007) 872 – 2008/0002
(COD) (2008) adopted on the 22 June 2009.
86 European Commission, Report from the Commission to the
European Parliament and the Council on Animal Cloning for
Food Production COM(2010) 585, at p. 14.
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surveys have shown that consumers do not actively
buy GMOs. It can deduced from a broad survey
involving ten EU countries between 2006 and 2008
which concluded that consumers are not careful
about avoiding GM products as they do not actually
look at the label.87 Genetic modification is not
a food characteristic that is sought out by con-
sumers, unlike organic products. Therefore, remov-
ing cloned products from supermarket shelves does
reduce consumers’ decision-making capacity.
The European institutions appear to listen to con-
sumer preferences and to adopt a precautionary
approach towards the use of animal cloning for
farming purposes – as they did for GMOs. In con-
trast, the UK government fails to acknowledge that
its present policy on animal cloning is on opposi-
tion with the European Parliament and the Council
as they want a ban on animal cloning while the
Commission proposed a temporary suspension. By
allowing the technique, the UK appears to be iso-
lated from the EU institutions but also from the
public – which raises issues as to the moral legiti-
macy of the new policy.88
As it stands, animal cloning would also seem to
be contrary to Article 13 of the Treaty on the Func-
tioning of the European Union (TFEU) which in-
corporated the Additional Protocol on Protection
and Welfare of Animals to the Amsterdam Treaty
which recognises that animals are ‘sentient beings’
and obliges EU Member States to take full account
of the welfare requirements of animals when for-
mulating and implementing EU legislation.89 The
EGE confirms this understanding by declaring that
it has ‘doubts whether infringements of these stan-
dards can be justified by the benefits obtained by
current procedures in cloning animals for food
production’.90 Moreover, the EU Animal Health
Strategy (2007–2013) focuses on issues linked to
animal health, such as public health, food safety and
animal welfare.91 Animal cloning for food con-
sumption seems to contravene EU law and policy
due to its associated impacts and risks to animal
health and welfare. Thus, the UK position might
also be contrary to EU provisions, especially as Arti-
cles 20 and 21 of Council Directive 98/58/EC were
implemented by Paragraphs 28 and 29 of Schedule I
to the Welfare of Farmed Animals (England) Regu-
lations 2007. 
3. A Lack of Agreement on Labelling
The review process of the proposal, nonetheless,
failed at the end of March 2011 as the dialogue
between the European Parliament, the Council
and the Commission finished in deadlock.92 The
labelling of the offspring of cloned animals,
emerged as the most contentious issue and is the
reason why the conciliation process failed. The
European Parliament supported the mandatory
labelling of any products from the offspring of
clones and, therefore, a full system of traceability
which would have allowed consumer information
and choice. The Council only wanted to label fresh
meat – which would have excluded cloned milk.93
As to the Commission, it did not consider the prod-
ucts from the offspring of clones to require manda-
tory labelling.94 The UK policy here is in line with
the Commission’s position. The Council and the
Commission argued that it would not have been
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87 King’s College London, “Do European Consumers Buy GM
Foods?” (‘Consumerchoice’) (2008), at paras. 1–11. The ten EU
countries were the Czech Republic, Estonia, Germany, Greece,
the Netherlands, Poland, Slovenia, Spain, Sweden and the
United Kingdom.
88 As will be observed in section V.
89 TFEU, Article 13. See, in relation to the protection of animal
welfare in the EU in both legislation and case law, Rasso Ludwig
and Roderic O’Gorman, “A Cock and Bull Story? Problems with
the Protection of Animal Welfare in EU Law and some Proposed
Solutions” 20 Journal of Environmental Law (2008), pp. 363 et
sqq. This incorporation put an end to the weakness of the status
of the protocol, as it had been established in the Jippes Case.
See, Case C-189/01 H. Jippes, Afdeling Groningen van de
Nederlandse Vereniging tot Bescherming van Dieren and
Afdeling Assen en omstreken van de Nederlandse Vereniging
tot Bescherming van Dieren v. Minister van Landbouw, 
Natuurbeheer en Visserij [2001] ECR I-5689 ), at para. 73. 
For a comment of the case, see Eleanor Spaventa, “Annotation
on Jippes” 39 Common Market Law Review (2003), pp. 1159
et sqq.
90 EGE, Opinion on the Ethical Aspects of Animal Cloning, supra
note 11, at p. 39.
91 See European Commission, Directorate General for Health and
Consumers, “The New Animal Health Strategy (2007–2013):
‘Prevention is Better than Cure”’, 3 November 2008, available 
on the internet at <http://ec.europa.eu/food/animal/diseases/
strategy/index_en.htm> (last accessed on 20 November 2012).
92 For a useful summary, see Euractiv, “Novel Foods Review Stum-
bles over Cloning”, 29 March 2011, available on the internet at
<http://www.euractiv.com/en/cap/novel-foods-review-stumbles-
cloning-news-503610?utm_source=EurActiv+Newsletter&utm_
campaign=978ddd2130-my_google_analytics_key&utm_
medium=email> (last accessed on 20 November 2012).
93 Ibid.
94 European Commission, Report 2010, supra note 86, at p. 14.
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feasible because of the lack of technology being able
to detect the difference.95 The UK, like the Council
and the Commission, fails to consider consumer
preferences.
This review has led to a regulatory conundrum, a
Catch 22 situation. It demonstrated that disagree-
ments existed at two levels within the EU institu-
tions: first, a disagreement about risks and ade-
quacy of scientific data as shown by the opinions
provided by the EFSA and the EGE; and second, a
divergence on how to deal with animal cloning and
its resulting foods, that is the regulatory solution
that should be put in place.
Because the process failed, a new proposal has
now to be submitted. Agreeing on another text
could take up to three years – as did this process –
and could end again in an impasse. At the time of
writing, no such proposal has been submitted.96
Even though it lacked final agreement, a shift in
the negotiating positions occurred during the
review. These changes in position show, nonethe-
less, the growing influence that consumers can have
on the decision-making process. 
Currently, cloned foods fall under the scope of
the Novel Foods Regulation and could not be
required to be labelled, which reinstates the use of
the principle of substantial equivalence and its
inadequacies at the heart of the system. The EU usu-
ally adopts a ‘better safe than sorry’ or precaution-
ary approach to manage the uncertainty created by
biotech foods. But in the case of animal cloning, it is
currently failing to do so. The European Parliament
has prevented a ‘weak’ legislation, but as a conse-
quence allows a ‘weaker’ legislation to continue to
apply. Effectively, as substantial equivalence leads
to the limited labelling of cloned foods and their
traceability, if a food safety issue would arise,
governmental action would be highly restricted and
slow. Also, the real extent of the permeability of
cloned foods within the food system could not be
assessed. 
V. A Meaningful Role for Consumers?
As will be now demonstrated, consumers are resist-
ant towards animal cloning and its derived foods.
This can be contrasted with the lack of mandatory
labelling, which prevents consumers from knowing
what they eat. The new UK policy departs from
developments which tend to listen to public per-
spective. In particular, there is a growing tendency
for supermarkets to accommodate consumer pre-
ferences in relation to biotech foods. All these
elements raise questions as to the legitimacy and
effectiveness of the UK regime.
1. Consumer Attitudes
Consumer surveys have demonstrated and con-
firmed concerns about animal cloning and its
derived foods. In a 2008 FSA research on the views
of the UK public about animal cloning and their
products, results showed that the key areas of con-
cern raised by the public were food safety, the lack
of consumer benefits, animal welfare and the lack
of trust in the key players involved.97 Participants
felt ‘as uncomfortable buying and consuming food
derived from the offspring of clones as they would
about food derived directly from clones’.98 More
importantly, the survey showed that the UK public
favoured a strong regulatory regime to be estab-
lished where clones and their offspring should be
traceable and labelled to enable consumers to make
an informed choice; to increase consumer confi-
dence; and to allow the monitoring of such technol-
ogy.99 Moreover, UK consumers are not alone in
their concerns about animal cloning and its derived
foods, as EU surveys have disclosed comparable
results. In a 2008 Eurobarometer on Europeans’
attitudes towards animal cloning, nine out of ten
EU citizens considered it crucial that food products
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from offspring of cloned animals should be
labelled.100 Both UK and EU surveys show that
consumers want to know the origin of their foods.
They want consumer choice through labelling. 
2. Consumers: a Market Force 
of their Own?
As a result of the failure of the review of the Novel
Foods Regulation, at the end of March 2011, six of
the UK largest supermarkets pledged to keep meat
and milk from cloned animals and their offspring
off their shelves.101 Such a position reflects popular
demand: supermarkets are following the prefer-
ences and perceptions of consumers – as evidenced
in the surveys. Such a de facto ban recalls the (lack
of) development of GMOs in the UK, as consumer
are resistant to them.102 A similar ban was put in
place and still exists for GMOs and GM foods. It
started in 1998 when Iceland removed all GM ingre-
dients from its own labelled products and was then
joined by more UK supermarkets.103 Subsequently,
this prevented the GM market from taking off. As
stated by Bodiguel and Cardwell, ‘sections of the
public ... would seem to have influenced the pace at
which GMOs are being developed, and also their
market penetration’.104 The impact of banning ani-
mal cloning by major retailers will most likely limit
the development and commercialisation of animal
cloning and their derived products.
In relation to GMOs, in January 2012 the German
biotech and chemical company BASF announced
the withdrawal of its research and development
operations on GM crops in the European market.
The main reason was the lack of consumer accept-
ance for GM plants and foods combined with farm-
ers and politicians’ hostility.105 Along the same line,
in February 2012, the biotech company Monsanto
declared that it would abandon the sale of GM
MON810 maize in France from 2012 because of the
opposition from the public and the French authori-
ties. Monsanto deemed that ‘favourable conditions
for the sale of the MON810 in France in 2012 and
beyond are not in place’.106 These two events show
the weight that consumers and their preferences
can have on multinationals and their market devel-
opment. Thus, through various means, consumer
preferences tend to be accommodated by different
actors. Nonetheless, the UK governmental position
is stepping into the opposite direction where eco-
nomic expansion necessitates the use of modern
biotechnology, without fully considering the conse-
quences of such a decision on the public, the ani-
mals, their health and the environment.
3. The ‘Right Kind Of ’ Policy
New technologies create a twofold challenge for
regulators: the question of the legitimacy and effec-
tiveness of their interventions.107 The question is
whether the regulators are ‘doing the right thing’,
whether their intervention passes moral muster.108
It was mentioned in this article that the objective of
the UK policy on animal cloning was economic
growth and that such an objective was a legitima-
tion of the new policy. The legitimacy of regulatory
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purposes is however different. The simple fact that
consumer preferences towards animal cloning and
cloned foods were ignored by the UK government
questions the moral legitimacy of this new policy
on animal cloning. According to Brownsword,
regulators should operate in an ‘evidence-based’
manner.109 In the case of the cloning strategy, it
seems that the evidence is pointing to the contrary
of the decisions taken.
As to the effectiveness of the animal cloning pol-
icy in serving its intended purpose, the regulatory
approach seems adequate to improve the develop-
ment of the biotech industry and therefore favour
economic growth by requiring no pre-market autho-
risation or labelling. As stated by Sunstein, strin-
gent regulation ‘might well deprive society of signif-
icant benefits’.110 Concerning the appropriateness
of the regulatory approach, however, the fact that
no mandatory labelling is required prevents the
public from knowing what they eat. The new policy
fails to consider the full range of available regula-
tory instruments, which leads back to the absence
of legitimacy of the chosen regulatory purposes.
Therefore, as the objectives are not regarded as
legitimate, the regulatory intervention lacks effec-
tiveness.
The current ‘laissez-faire’ regime could have
negative effects. Sometimes ‘regulators can make
things worse by intervening because the interven-
tion produces unintended consequences.’111 Here,
the governmental intervention, more precisely lack
of intervention, might lead to unwanted effects, as
it did with the StarLink™ incident. Requiring
the mandatory labelling of products derived from
cloned animals and their descendants appears to be
a good compromise: it provides consumers with
safe food and the information they desire while still
allowing for the technology to develop until it is
more efficient and long term risk can be measured.
Finally, Brownsword argues that a regulatory sys-
tem is put the test if there is no consensus or
convergence of views within this system.112 Very
interestingly, in the case of animal cloning and its
derived foods (and as is the case for GMOs), a huge
majority of the UK public are against such a prac-
tice and agree on the mandatory labelling of its
resulting products as the lowest common denomi-
nator. Even though there is a strong agreement
within UK consumers rather than a consensus, this
should play a role in the regulation of animal
cloning. Consumers should be at the centre of the
regulation of biotech foods. If supermarkets are
listening to consumer preferences, it seems that the
regulators should do the same.
VI. Conclusion
A strong positive approach towards modern bio-
technology has been revived by the Coalition Gov-
ernment, where modern agricultural biotechnology
through sustainable intensification addresses new
threats of food security and sustainability. 
The debate over modern agricultural biotechnol-
ogy, its role in ensuring food security and sustain-
ability and economic growth, and how it should be
regulated will continue to grow as the EFSA pub-
lished at the beginning of 2012 a guidance on the
risk assessment of food and feed from genetically
modified animals and on animal health and welfare
aspects.113 This new technology and its resulting
foods will raise similar regulatory issues as cloned
and GM foods. 
This article has identified various issues with the
current governmental policy call for the use of ani-
mal cloning for farming purposes. Those issues
weaken to a tremendous extent the legitimacy and
effectiveness of the regulatory intervention. First,
animal cloning is promoted without fully consider-
ing its negative (environmental) impacts, without
establishing appropriate controls, for example in
relation to genetic diversity, and without the
mandatory labelling of the offspring of clones.
Second, economic reasons have been identified to
be behind such a policy. A driving force towards
technological development, the promotion of ani-
mal cloning and its resulting financial benefits has
been demonstrated. Third, allowing animal cloning
puts the UK apart from the EU political institutions
as they agreed, in principle, on a temporary ban of
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the technology. Fourth, animal cloning for food
consumption seems contrary to both UK and EU
laws because of the animal welfare issues it raises.
Fifth, there is a developing trend to listen and to
accommodate consumer attitudes, where con-
sumers emerge as a separate market force. For
instance, the EU showed willingness to listen to
public views during the review of the Novel Foods
Regulation, even if it failed. However, the UK
government with this new policy is heading in the
opposite direction as consumer information and
choice are highly limited. 
The regulation of modern agricultural biotechnol-
ogy involves moral, social, societal and cultural
values which should be considered by policy- and
decision-makers and should play a decisive role in
the decision-making process. A framework respect-
ing such criteria – that combines both social needs
and regulatory (including technological develop-
ment) needs – would endow a new regime with
legitimacy and effectiveness. Ignoring consumer
preferences, animal health and welfare issues, and
environmental impacts could create further con-
straints and put the UK system in peril.
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